PDCD1 and neoplasm: The combination of the PC7A nanovaccine and an anti-PD-1 antibody showed great synergy, with increase survival rate in animal tumor models; tumor growth was completely inhibited when these vaccinated animals, suggesting generation of antitumor memory (176).